SCHEMBL23923148

SCHEMBL23923148

CC(C)C(=O)Oc1ccc(O)c(C(C)(C)C)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ATM Q13315 2/20 0.63
GAA P10253 2/20 0.63
XBP1 P17861 1/20 0.63
NPSR1 Q6W5P4 1/20 0.63
L3MBTL1 Q9Y468 1/20 0.63
NR1H4 Q96RI1 7/20 0.57
POLB P06746 1/20 0.55
MAPT P10636 1/20 0.55
ALDH1A1 P00352 3/20 0.54
ESRRA P11474 3/20 0.54
ELANE P08246 2/20 0.49
NR1I2 O75469 1/20 0.46
LMNA P02545 1/20 0.46
CYP2C9 P11712 1/20 0.46
MIF P14174 1/20 0.46
TYR P14679 1/20 0.46
ALOX15 P16050 1/20 0.46
HTT P42858 1/20 0.46
NFE2L2 Q16236 1/20 0.46
HSD17B10 Q99714 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27493344 0.89 ATM (0.61) ATMGAAXBP1NPSR1L3MBTL1
SCHEMBL25876672 0.86 ATM (0.59) ATMGAAXBP1NPSR1L3MBTL1
SCHEMBL28460208 0.85 ATM (0.68) ATMGAAXBP1NPSR1L3MBTL1
SCHEMBL29160645 0.85 ATM (0.57) ATMGAAXBP1NPSR1L3MBTL1
SCHEMBL11143326 0.85 ESRRA (0.62) ATMGAAXBP1NPSR1L3MBTL1
SCHEMBL27501224 0.81 CA2 (0.53) ATMGAAXBP1NPSR1L3MBTL1
SCHEMBL28670923 0.81 ELANE (0.53) ATMGAAXBP1NPSR1L3MBTL1
SCHEMBL18157016 0.80 NR1H4 (0.60) ATMGAAXBP1NPSR1L3MBTL1
SCHEMBL8985728 0.79 CYP1A2 (0.47) ATMGAAXBP1NPSR1L3MBTL1
SCHEMBL28876789 0.79 ATM (0.64) ATMGAAXBP1NPSR1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220017474-A1 Novel Polycyclic Compound EUTEC NEW MATERIALS TECHNOLOGY (SUZHOU) CO., LTD. (CN) 2022-01-20 US disclosed
EP-3896067-A1 NOVEL POLYCYCLIC COMPOUND Eutec New Materials Technology (Suzhou) Co., Ltd (CN) 2021-10-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220017474-A1 Novel Polycyclic Compound CUTA, DSG1, UACA ATM 2719/4885GAA 3423/4885XBP1 3031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.